About Trinity Biotech PLC (NASDAQ:TRIB)
Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Diagnostic & Testing Substances Manufacturers
- Sub-Industry: N/A
- Symbol: NASDAQ:TRIB
- CUSIP: N/A
- Web: www.trinitybiotech.com
- Market Cap: $122.85 million
- Outstanding Shares: 21,847,000
- 50 Day Moving Avg: $5.39
- 200 Day Moving Avg: $5.58
- 52 Week Range: $5.09 - $7.40
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 30.06
- P/E Growth: 1.26
- Annual Revenue: $98.79 million
- Price / Sales: 1.13
- Book Value: $4.89 per share
- Price / Book: 1.04
- EBITDA: $7.39 million
- Net Margins: -100.45%
- Return on Equity: 5.54%
- Return on Assets: 2.70%
- Debt-to-Equity Ratio: 0.89%
- Current Ratio: 5.33%
- Quick Ratio: 3.88%
- Average Volume: 40,318 shs.
- Beta: 1.33
- Short Ratio: 14.42
Frequently Asked Questions for Trinity Biotech PLC (NASDAQ:TRIB)
What is Trinity Biotech PLC's stock symbol?
Trinity Biotech PLC trades on the NASDAQ under the ticker symbol "TRIB."
How were Trinity Biotech PLC's earnings last quarter?
Trinity Biotech PLC (NASDAQ:TRIB) posted its earnings results on Thursday, July, 21st. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.06 by $0.03. The company earned $26.30 million during the quarter, compared to the consensus estimate of $24.30 million. Trinity Biotech PLC had a negative net margin of 100.45% and a positive return on equity of 5.54%. View Trinity Biotech PLC's Earnings History.
When will Trinity Biotech PLC make its next earnings announcement?
Who are some of Trinity Biotech PLC's key competitors?
Some companies that are related to Trinity Biotech PLC include Strongbridge Biopharma PLC (SBBP), Mirna Therapeutics (SYBX), vTv Therapeutics (VTVT), Vital Therapies (VTL), Threshold Pharmaceuticals (MTEM), Chimerix (CMRX), Catalyst Pharmaceuticals (CPRX), Nabriva Therapeutics AG (NBRV), Athersys (ATHX), Pieris Pharmaceuticals (PIRS), Kindred Biosciences (KIN), Sorrento Therapeutics (SRNE), Cascadian Therapeutics (CASC), Neos Therapeutics (NEOS), Spring Bank Pharmaceuticals (SBPH), AAC Holdings (AAC), Mast Therapeutics (SVRA) and Anavex Life Sciences Corp. (AVXL).
Who are Trinity Biotech PLC's key executives?
Trinity Biotech PLC's management team includes the folowing people:
- Ronan O'Caoimh, Executive Chairman of the Board
- Kevin Tansley, Chief Financial Officer, Secretary
- Rory Nealon, Chief Operating Officer, Executive Director
- Eric Brouwer Ph.D., Chief Scientific Officer, and Vice President Cardiac
- James Walsh Ph.D., Executive Director
- Clinton H. Severson, Non-Executive Director
- Denis R. Burger Ph.D., Senior Non-Executive Independent Director
- Peter Coyne, Non-Executive Independent Director
- James D. Merselis, Non-Executive Independent Director
Who owns Trinity Biotech PLC stock?
How do I buy Trinity Biotech PLC stock?
Shares of Trinity Biotech PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Trinity Biotech PLC's stock price today?
MarketBeat Community Rating for Trinity Biotech PLC (NASDAQ TRIB)MarketBeat's community ratings are surveys of what our community members think about Trinity Biotech PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Trinity Biotech PLC stock can currently be purchased for approximately $5.11.
Earnings History for Trinity Biotech PLC (NASDAQ:TRIB)Earnings History by Quarter for Trinity Biotech PLC (NASDAQ TRIB)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|7/20/2017||6/30/2017||$0.06||$0.03||$24.83 million||$25.45 million||View||N/A|
|4/27/2017||3/31/2017||$0.03||$0.01||$24.24 million||$23.54 million||View||N/A|
|10/25/2016||Q3||$0.07||$0.07||$26.50 million||$26.10 million||View||Listen|
|7/21/2016||Q2||$0.06||$0.09||$24.30 million||$26.30 million||View||Listen|
|4/19/2016||Q1||$0.08||$0.06||$24.34 million||$23.52 million||View||Listen|
|3/3/2016||Q4||$0.09||$0.29||$251.00 million||$271.20 million||View||N/A|
|10/22/2015||Q3||$0.09||$0.10||$25.40 million||$27.20 million||View||Listen|
|7/28/2015||Q2||$0.14||$0.07||$26.09 million||$24.26 million||View||Listen|
|4/30/2015||Q115||$0.17||$0.17||$25.93 million||$25.20 million||View||N/A|
|3/3/2015||Q414||$0.18||$0.18||$27.30 million||$26.70 million||View||N/A|
|10/23/2014||Q114||$0.20||$0.19||$27.30 million||$27.20 million||View||Listen|
|7/29/2014||Q413||$0.20||$0.18||$27.00 million||$26.00 million||View||N/A|
|4/29/2014||$0.19||$0.18||$25.48 million||$25.03 million||View||N/A|
|10/17/2013||Q313||$0.21||$0.21||$24.68 million||$24.10 million||View||N/A|
|7/30/2013||Q2 2013||$0.20||$0.21||$22.03 million||$21.30 million||View||N/A|
|3/5/2013||Q4 2012||$0.21||$0.20||$21.84 million||$20.80 million||View||N/A|
Earnings Estimates for Trinity Biotech PLC (NASDAQ:TRIB)
2017 EPS Consensus Estimate: $0.26
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History by Quarter for Trinity Biotech PLC (NASDAQ TRIB)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading History for Trinity Biotech PLC (NASDAQ:TRIB)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Trinity Biotech PLC (NASDAQ:TRIB)
Latest Headlines for Trinity Biotech PLC (NASDAQ:TRIB)
Loading headlines, please wait.
Trinity Biotech PLC (TRIB) Chart for Sunday, October, 22, 2017